Page 168 - MemoriaCIBER-2017ESP

Producción Cientí ca
PUBLICACIONES
No de publicaciones en 2017
365 Q1 271
TOTAL
D1
130
Publicaciones más relevantes del CIBERONC durante 2017 según factor de impacto
Publicación
Factor Impacto
Rami-Porta R , Asamura H , Travis W D , Rusch V W Lung cancer — major changes in the
American Joint Committee on Cancer eighth edition cancer staging manual CA Cancer Journal 187,04 for Clinicians 2017;67(2):138-155
Kantarjian H , Stein A , Gokbuget N , Fielding A K , Schuh A C , Ribera J -M et al Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia New England Journal of Medicine 2017;376(9):836-847
72,406
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R et al Durvalumab after
Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer The New England journal of 72,406 medicine 2017
El-Khoueiry A B , Sangro B , Yau T , Crocenzi T S , Kudo M , Hsu C et al Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1/2 dose escalation and expansion trial The Lancet 2017
47,831
Powles T , Duran I , van der Heijden M S , Loriot Y , Vogelzang N J , De Giorgi U et al Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): A multicentre, open-label, phase 3 randomised controlled trial The Lancet 2017
47,831
Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H et al Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial Lancet (London, England) 2017
47,831
Reig M , Bruix J Lenvatinib: can a non-inferiority trial change clinical practice? The Lancet 2018;391(10126):1123-1124
Michailidou K , Lindstrom S , Dennis J , Beesley J , Hui S , Kar S et al Association analysis identi es 65 new breast cancer risk loci Nature 2017;551(7678):92-94
47,831
40,137
Zabala-Letona A , Arruabarrena-Aristorena A , Martin-Martin N , Fernandez-Ruiz S , Sutherland J D , Clasquin M et al MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer Nature 2017;547(7661):109-113
40,137
Cobo I , Martinelli P , Flandez M , Bakiri L , Zhang M , Carrillo-De-Santa-Pau E et al Transcriptional regulation by NR5A2 links di erentiation and in ammation in the pancreas Nature 2018;554(7693):533-537
40,137
168 CIBER MEMORIA ANUAL 2017